M Koesters, T Becker, R Kilian, JM Fegert, and S Weinmann

Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder
J Psychopharmacol 2009 23: 733-744. [Abstract] [PDF] [References] [Request Permission]  

K Soar, A Parrott, and J Turner

Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users
J Psychopharmacol 2009 23: 745-758. [Abstract] [PDF] [References] [Request Permission]  

K Allott, BJ Canny, JH Broadbear, NK Stepto, B Murphy, and J Redman

Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users
J Psychopharmacol 2009 23: 759-774. [Abstract] [PDF] [References] [Request Permission]  

P Keedwell, D Drapier, S Surguladze, V Giampietro, M Brammer, and M Phillips

Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score
J Psychopharmacol 2009 23: 775-788. [Abstract] [PDF] [References] [Request Permission]  

MX Patel, N De Zoysa, M Bernadt, and A David

Depot and oral antipsychotics: patient preferences and attitudes are not the same thing
J Psychopharmacol 2009 23: 789-796. [Abstract] [PDF] [References] [Request Permission]  

JT Andreasen, GM Olsen, O Wiborg, and JP Redrobe

Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests
J Psychopharmacol 2009 23: 797-804. [Abstract] [PDF] [References] [Request Permission]  

T Messer, T Glaser, H Landen, and M Schmauss

Long-term treatment with flupentixol results of a post-marketing surveillance study
J Psychopharmacol 2009 23: 805-813. [Abstract] [PDF] [References] [Request Permission]  

CK Martin, H Han, SD Anton, FL Greenway, and SR Smith

Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial
J Psychopharmacol 2009 23: 814-825. [Abstract] [PDF] [References] [Request Permission]  

JM Le Melledo, K Mailo, N Lara, MC Abadia, L Gil, M Van Ameringen, G Baker, and J Perez-Parada

Paroxetine-induced increase in LDL cholesterol levels
J Psychopharmacol 2009 23: 826-830. [Abstract] [PDF] [References] [Request Permission]  

N Antypa, AJW Van der Does, AHM Smelt, and RD Rogers

Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers
J Psychopharmacol 2009 23: 831-840. [Abstract] [PDF] [References] [Request Permission]  

M Ebinger, C Sievers, D Ivan, HJ Schneider, and GK Stalla

Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?
J Psychopharmacol 2009 23: 841-853. [Abstract] [PDF] [References] [Request Permission]  

T Eller, V Vasar, J Shlik, and E Maron

Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major depressive disorder
J Psychopharmacol 2009 23: 854-858. [Abstract] [PDF] [References] [Request Permission]  

S Ruiz-Doblado, T Rueda-Villar, and L Casillas-Lara

High-dose venlafaxine in delusional and severely depressed patients
J Psychopharmacol 2009 23: 859-860. [PDF] [References] [Request Permission]  

Erratum
J Psychopharmacol 2009 23: 861. [PDF] [Request Permission]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.